1. Home
  2. MTSR vs IAC Comparison

MTSR vs IAC Comparison

Compare MTSR & IAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MTSR
  • IAC
  • Stock Information
  • Founded
  • MTSR 2022
  • IAC N/A
  • Country
  • MTSR United States
  • IAC United States
  • Employees
  • MTSR N/A
  • IAC N/A
  • Industry
  • MTSR
  • IAC Computer Software: Programming Data Processing
  • Sector
  • MTSR
  • IAC Technology
  • Exchange
  • MTSR NYSE
  • IAC Nasdaq
  • Market Cap
  • MTSR 3.0B
  • IAC 2.8B
  • IPO Year
  • MTSR 2025
  • IAC 1992
  • Fundamental
  • Price
  • MTSR $29.60
  • IAC $37.14
  • Analyst Decision
  • MTSR Strong Buy
  • IAC Strong Buy
  • Analyst Count
  • MTSR 6
  • IAC 14
  • Target Price
  • MTSR $55.25
  • IAC $53.07
  • AVG Volume (30 Days)
  • MTSR 1.0M
  • IAC 945.3K
  • Earning Date
  • MTSR 05-12-2025
  • IAC 08-05-2025
  • Dividend Yield
  • MTSR N/A
  • IAC N/A
  • EPS Growth
  • MTSR N/A
  • IAC N/A
  • EPS
  • MTSR N/A
  • IAC N/A
  • Revenue
  • MTSR N/A
  • IAC $3,753,432,000.00
  • Revenue This Year
  • MTSR N/A
  • IAC N/A
  • Revenue Next Year
  • MTSR N/A
  • IAC $0.64
  • P/E Ratio
  • MTSR N/A
  • IAC N/A
  • Revenue Growth
  • MTSR N/A
  • IAC N/A
  • 52 Week Low
  • MTSR $12.30
  • IAC $32.05
  • 52 Week High
  • MTSR $37.99
  • IAC $45.45
  • Technical
  • Relative Strength Index (RSI)
  • MTSR N/A
  • IAC 53.11
  • Support Level
  • MTSR N/A
  • IAC $35.48
  • Resistance Level
  • MTSR N/A
  • IAC $37.88
  • Average True Range (ATR)
  • MTSR 0.00
  • IAC 0.98
  • MACD
  • MTSR 0.00
  • IAC 0.05
  • Stochastic Oscillator
  • MTSR 0.00
  • IAC 71.21

About MTSR METSERA INC

Metsera Inc is a clinical-stage biotechnology company developing next-generation injectable and oral nutrient-stimulated hormone (NuSH) analog peptides to treat obesity, overweight, and related conditions. The Company has developed and is implementing proprietary methods and platform technologies to advance a broad, scalable, and combinable portfolio of injectable and oral NuSH analog peptides with the potential to address not only the limitations of approved therapies but also many of the anticipated limitations of next-generation therapies in development. The Company uses its proprietary MINT peptide library of NuSH analog peptides alongside its Half-life Augmentation by Lipid Optimization half-life extending platform.

About IAC IAC Inc.

IAC Inc is comprised of businesses including Angi Inc, Dotdash Meredith and Care.com, among many others ranging from early stage to established businesses. Its Dotdash Meredith segment consists of its Digital and Print businesses. Angi segment offers repairing and remodeling homes to cleaning and landscaping services. Care.com segment is a online destination for families to connect with caregivers for their children, aging parents, pets and homes and for caregivers to connect with families seeking care services. Search segment consists of a collection of websites providing general search services and information, and a Desktop business, which includes business-to-business partnership operations.

Share on Social Networks: